Article Commentary: Clostridium difficile and the Surgeon

Bartlett J.G. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin Infect Dis 2008; 46(suppl 1): S4–11.

Hurley B.W. , Nguyen C.C. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea. Arch Intern Med 2002; 162: 2177–84.

Kyne L. , Farrell R.J. , Kelly C.P. Clostridium difficile. Gastro-enterol Clin North Am 2001; 30: 753–77, ix–x.

Mylonakis E. , Ryan E.T. , Calderwood S.B. Clostridium difficile-associated diarrhea: a review. Arch Intern Med 2001; 161: 525–33.

Greenstein A.J. , Byrn J.C. , Zhang L.P. Risk factors for the development of fulminant Clostridium difficile colitis. Surgery 2008; 143: 623–9.

Halsey J. Current and future treatment modalities for Clostridium difficile-associated disease. Am J Health Syst Pharm 2008; 65: 705–15.

Adams S.D. , Mercer D.W. Fulminant Clostridium difficile colitis. Curr Opin Crit Care 2007; 13: 450–5.

Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile-associated disease in populations previously at low risk—four states, 2005. MMWR Morb Mortal Wkly Rep 2005; 54: 1201–5.

Goorhuis A. , Bakker D. , Corver J. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008; 47: 1162–70.

Aslam S. , Musher D.M. An update on diagnosis, treatment, and prevention of Clostridium difficile-associated disease. Gastroenterol Clin North Am 2006; 35: 315–35.

Dallal R.M. , Harbrecht B.G. , Boujoukas A.J. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002; 235: 363–72.

Longo W.E. , Mazuski J.E. , Virgo K.S. Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum 2004; 47: 1620–6.

Loo V.G. , Poirier L. , Miller M.A. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353: 2442–9.

Giannasca P.J. , Warny M. Active and passive immunization against Clostridium difficile diarrhea and colitis. Vaccine 2004; 22: 848–56.

Lamontagne F. , Labbé A.C. , Haeck O. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg 2007; 245: 267–72.

Mazuski J. Clostridium difficile colitis. Probl Gen Surg 2002; 19: 121–32.

Hookman P. , Barkin J.S. Review: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis: the emergence of a more virulent era. Dig Dis Sci 2007; 52: 1071–5.

Pepin J. , Vo T.T. , Boutros M. Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum 2009; 52: 400–5.

Byrn J.C. , Maun D.C. , Gingold D.S. Predictors of mortality after colectomy for fulminant Clostridium difficile colitis. Arch Surg 2008; 143: 150–4; discussion 155.

Koss K. , Clark M.A. , Sanders D.S. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis 2005; 8: 149–54.

Hui R.K. , Zeng F. , Chan C.M. Reverse transcriptase PCR diagnostic assay for the coronavirus associated with severe acute respiratory syndrome. J Clin Microbiol 2004; 42: 1994–9.

Barbut F. , Kajzer C. , Planas N. , Petit J.C. Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol 1993; 31: 963–7.

Reller M.E. , Lema C.A. , Perl T.M. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol 2007; 45: 3601–5.

Bartlett J.G. , Gerding D.N. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008; 46(suppl 1): S12–8.

Mohan S.S. , McDermott B.P. , Parchuri S. , Cunha B.A. Lack of value of repeat stool testing for Clostridium difficile toxin. Am J Med, 2006. 119: 356.e7–8.

Wolfhagen M.J. , Meijer K. , Fluit A.C. Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children. Gut 1994; 35: 1608–12.

Zheng L. , Keller S.F. , Lyerly D.M. Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens. J Clin Microbiol 2004; 42: 3837–40.

Ticehurst J.R. , Aird D.Z. , Dam L.M. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 2006; 44: 1145–9.

Morris J.B. , Zollinger R.M. Jr. , Stellato T.A. Role of surgery in antibiotic-induced pseudomembranous enterocolitis. Am J Surg 1990; 160: 535–9.

Medich D.S. , Lee K.K. , Simmons R.L. Laparotomy for fulminant pseudomembranous colitis. Arch Surg 1992; 127: 847–52; discussion 852–3.

Malnick S.D. , Zimhony O. Treatment of Clostridium difficile-associated diarrhea. Ann Pharmacother 2002; 36: 1767–75.

Pepin J. , Alary M.E. , Valiquette L. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005; 40: 1591–7.

Musher D.M. , Logan N. , Mehendiratta V. Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide. J Antimicrob Chemother 2007; 59: 705–10.

Sunenshine R.H. , McDonald L.C. Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med 2006; 73: 187–97.

Apisarnthanarak A. , Razavi B. , Mundy L.M. Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature. Clin Infect Dis 2002; 35: 690–6.

Bouza E.D. , Mohammed M. , Peppe R. Clositridium difficile—Changing Epidemiology and Treatment Options. 18th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 2008. Abstract.

Garey K.W. , Salazar M. , Shah D. Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea. Ann Pharmacother 2008; 42: 827–35.

Taylor C. , Tummala S. , Molrine D. Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A. Vaccine 2008; 26: 3404–9.

Fekety R. , McFarland L.V. , Surawicz C.M. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997; 24: 324–33.

Jobe B.A. , Grasley A. , Deveney K.E. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg 1995; 169: 480–3.

Bradbury A.W. , Barrett S. Surgical aspects of Clostridium difficile colitis. Br J Surg 1997; 84: 150–9.

Bartlett J.G. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006; 145: 758–64.

Ricciardi R. , Ogilvie J.W. Jr. , Roberts P.L. Epidemiology of Clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases. Dis Colon Rectum 2009; 52: 40–5.

What Is Clostridium difficile? Frequently Asked Questions: Information for Healthcare Providers 2004. July 22, 2005. Available at: www.cdc.gov/ncidod/dhqp/id_CdiffFAQ_HCP.html. Accessed December 28, 2008.

Gerding D.N. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis 2004; 38: 646–8.

Muto C.A. , Pokrywka M. , Shutt K. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005; 26: 273–80.

Kelly C.P. , LaMont J.T. Clostridium difficile—more difficult than ever. N Engl J Med 2008; 359: 1932–40.

Hickson M. , D'Souza A.L. , Muthu N. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007; 335: 80.

Grundfest-Broniatowski S. , Quader M. , Alexander F. Clostridium difficile colitis in the critically ill. Dis Colon Rectum 1996; 39: 619–23.

Lipsett P.A. , Samantaray D.K. , Tam M.L. Pseudomem-branous colitis: a surgical disease? Surgery 1994; 116: 491–6.

Clabots C.R. , Johnson S. , Olson M.M. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992; 166: 561–7.

Fazio V.W. Toxic megacolon in ulcerative colitis and Crohn's colitis. Clin Gastroenterol 1980; 9: 389–407.

Berman L. , Carling T. , Fitzgerald T.N. Defining surgical therapy for pseudomembranous colitis with toxic megacolon. J Clin Gastroenterol 2008; 42: 476–80.

Ali S.O. , Welch J.P. , Dring R.J. Early surgical intervention for fulminant pseudomembranous colitis. Am Surg 2008; 74: 20–6.

Hall J.F. , Berger D. Outcome of colectomy for Clostridium difficile colitis: a plea for early surgical management. Am J Surg 2008; 196: 384–8.

Noblett S.E. , Welfare M. , Seymour K. The role of surgery in Clostridium difficile colitis. BMJ 2009; 338: b1563.

Synnott K. , Mealy K. , Merry C. Timing of surgery for fulminating pseudomembranous colitis. Br J Surg 1998; 85: 229–31.

Morris L.L. , Villalba M.R. , Glover J.L. Management of pseudomembranous colitis. Am Surg 1994; 60: 548–51; discussion 551–2.

Viswanath Y.K. , Griffiths C.D. The role of surgery in pseudomembranous enterocolitis. Postgrad Med J 1998; 74: 216–9.

Williams R.N. , Hemingway D. , Miller A.S. Enteral Clostridium difficile, an emerging cause for high output ileostomy. J Clin Pathol, 2009; 62: 951–3.

Beckwith P.S. , Wolff B.G. , Frazee R.C. Ileorectostomy in the older patient. Dis Colon Rectum 1992; 35: 301–4.